Novast Labs Company Profile
What is the competitive landscape for NOVAST LABS
NOVAST LABS has forty-eight approved drugs.
There are six tentative approvals on NOVAST LABS drugs.
Summary for Novast Labs
| US Patents: | 0 |
| Tradenames: | 44 |
| Ingredients: | 27 |
| NDAs: | 48 |
Drugs and US Patents for Novast Labs
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novast Labs | DESOGESTREL AND ETHINYL ESTRADIOL | desogestrel; ethinyl estradiol | TABLET;ORAL-28 | 091234-001 | Jul 12, 2013 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Novast Labs | CHABELINA FE | ethinyl estradiol; norethindrone acetate | TABLET;ORAL-28 | 202962-001 | Apr 15, 2020 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| Novast Labs | CONJUGATED ESTROGENS | estrogens, conjugated | TABLET;ORAL | 214025-002 | Oct 15, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
